Medistim

Remuneration Information • Jan 21, 2016

Transfer of shares to CEO Medistim ASA

Transfer of shares to CEO Medistim ASA

Medistim ASA has transferred 10,000 shares to Medistim

CEO Kari Krogstad as part of her compensation for

2016. It is part of her agreement with the Board of

Medistim that she receives 10,000 shares if she is in

position as CEO until 1st of January 2016. The

agreement has been previously described in the

Company's Annual Report for 2014. Medistims share

price as of 01.01.2016 was 54.00 so the shares are

transferred at this cost. Medistim ASA has 196,000 own

shares and after the transfer to Kari Krogstad the

company has 186,000 own shares shares.

Krogstad agreement gives her additional 10,000 shares

in Medistim if she is in position until 2017. This is

also described in the Annual Report for 2014. The

Board of Medistim ASA has decided to award Kari

Krogstad with another 12,500 shares if she is in

position as CEO until 2018.

Kari Krogstad has after the latest transfer 90,000

shares in Medistim ASA.